GenoRisk: A polygenic risk score for Alzheimer's disease

INTRODUCTION: Recent clinical trials are considering inclusion of more than just apolipoprotein E (APOE) ε4 genotype as a way of reducing variability in analysis of outcomes. METHODS: Case‐control data were used to compare the capacity of age, sex, and 58 Alzheimer's disease (AD)–associated sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Dickson, Samuel P., Hendrix, Suzanne B., Brown, Bruce L., Ridge, Perry G., Nicodemus‐Johnson, Jessie, Hardy, Marci L., McKeany, Allison M., Booth, Steven B., Fortna, Ryan R., Kauwe, John S.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485054/
https://www.ncbi.nlm.nih.gov/pubmed/34621978
http://dx.doi.org/10.1002/trc2.12211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485054/
https://www.ncbi.nlm.nih.gov/pubmed/34621978
http://dx.doi.org/10.1002/trc2.12211

Ejemplares similares